LiuT. Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients. Lupus2014; 23: 958–963.
2.
BudhramA. Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus2014; 23: 1156–1163.
3.
Amaya-AmayaJ. Cardiovascular disease in Latin American patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. Autoimmune Dis2013, pp. 794383–794383.
4.
FrancoJ-S. The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians. PLoS One2014; 9: e110242–e110242.
5.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
6.
ArnettFC. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988; 31: 315–324.
KakumanuP. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol2009; 36: 2682–2690.
